77 related articles for article (PubMed ID: 12794721)
1. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy.
Schvoerer E; Navas MC; Thumann C; Fuchs A; Meyer N; Habersetzer F; Stoll-Keller F
J Med Virol; 2003 Aug; 70(4):588-93. PubMed ID: 12794721
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
Pham TN; Mercer SE; Michalak TI
J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
[TBL] [Abstract][Full Text] [Related]
4. [Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy].
Dong Y; Zhang HF; Chen H; Li J; Yang XJ; Zhu SS; Cheng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):364-6. PubMed ID: 19469176
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.
El-Kady IM; Lotfy M; Badra G; El-Masry S; Waked I
Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127
[TBL] [Abstract][Full Text] [Related]
6. [Peripheral blood T cell subsets and TH1/TH2 cytokines secretion in children with chronic hepatitis C virus infection].
Dong Y; Zhang HF; Chen H; Li J; Yang XJ; Zhu SS; Cheng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):26-8. PubMed ID: 17429527
[TBL] [Abstract][Full Text] [Related]
7. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
[TBL] [Abstract][Full Text] [Related]
8. Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection.
Aceti A; Mangoni ML; Pasquazzi C; Fiocco D; Marangi M; Miele R; Zechini B; Borro M; Versace I; Simmaco M
J Viral Hepat; 2006 Dec; 13(12):821-7. PubMed ID: 17109681
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection.
Meier V; Bürger E; Mihm S; Saile B; Ramadori G
J Med Virol; 2003 Jan; 69(1):50-8. PubMed ID: 12436477
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
Semmo N; Krashias G; Willberg C; Klenerman P
J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
Brady MT; MacDonald AJ; Rowan AG; Mills KH
Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
[TBL] [Abstract][Full Text] [Related]
17. Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection.
Martin-Blondel G; Gales A; Bernad J; Cuzin L; Delobel P; Barange K; Izopet J; Pipy B; Alric L
J Viral Hepat; 2009 Jul; 16(7):485-91. PubMed ID: 19302337
[TBL] [Abstract][Full Text] [Related]
18. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
Abayli B; Canataroğlu A; Akkiz H
Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
[TBL] [Abstract][Full Text] [Related]
19. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
20. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
Sun Y; Chen HY; Xin SJ
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
